Paper32208352
Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma.
Sun C and 21 others. Transl Oncol, 2020. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma. Papers, record 32208352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32208352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22394497 | Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation. | Neuro Oncol | 2012 | https://conductscience.org/library/papers/22394497 | PubMed |
| 2 | 29642018 | A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence. | Cell Rep | 2018 | https://conductscience.org/library/papers/29642018 | PubMed |
| 3 | 25908104 | Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. | Blood | 2015 | https://conductscience.org/library/papers/25908104 | PubMed |
| 4 | 29036500 | Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. | Neuro Oncol | 2018 | https://conductscience.org/library/papers/29036500 | PubMed |
| 5 | 26822025 | CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains. | Cancer Immunol Res | 2016 | https://conductscience.org/library/papers/26822025 | PubMed |
| 6 | 16616332 | Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16616332 | PubMed |
| 7 | 23550210 | Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. | Sci Signal | 2013 | https://conductscience.org/library/papers/23550210 | PubMed |
| 8 | 17616532 | Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17616532 | PubMed |
| 9 | 26339454 | Podoplanin increases migration and angiogenesis in malignant glioma. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26339454 | PubMed |
| 10 | 28531337 | Correlation of immune phenotype with IDH mutation in diffuse glioma. | Neuro Oncol | 2017 | https://conductscience.org/library/papers/28531337 | PubMed |
| 11 | 8876144 | Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8876144 | PubMed |
| 12 | 10607676 | Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. | Curr Opin Struct Biol | 1999 | https://conductscience.org/library/papers/10607676 | PubMed |
| 13 | 30972297 | Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression. | Front Oncol | 2019 | https://conductscience.org/library/papers/30972297 | PubMed |
| 14 | 24828042 | The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. | Nature | 2014 | https://conductscience.org/library/papers/24828042 | PubMed |
| 15 | 30760837 | DNA demethylation is associated with malignant progression of lower-grade gliomas. | Sci Rep | 2019 | https://conductscience.org/library/papers/30760837 | PubMed |
| 16 | 25341788 | Dendritic cells control fibroblastic reticular network tension and lymph node expansion. | Nature | 2014 | https://conductscience.org/library/papers/25341788 | PubMed |
| 17 | 25179419 | Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. | Hepatology | 2015 | https://conductscience.org/library/papers/25179419 | PubMed |
| 18 | 27186410 | Podoplanin - a small glycoprotein with many faces. | Am J Cancer Res | 2016 | https://conductscience.org/library/papers/27186410 | PubMed |
| 19 | 29453678 | Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas. | J Neurooncol | 2018 | https://conductscience.org/library/papers/29453678 | PubMed |
| 20 | 31004262 | Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours. | J Neurooncol | 2019 | https://conductscience.org/library/papers/31004262 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41648527 | Critical role of cell competition in gliomagenesis. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648527 | PubMed |
| 40741180 | The regulation of cancer-associated thrombosis by podoplanin. | Thromb Update | 2024 | https://conductscience.org/library/papers/40741180 | PubMed |
| 40554484 | Predicting podoplanin expression and prognostic significance in high-grade glioma based on TCGA TCIA radiomics. | PLoS One | 2025 | https://conductscience.org/library/papers/40554484 | PubMed |
| 40430568 | Near-Infrared Photoimmunotherapy in Brain Tumors-An Unexplored Frontier. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430568 | PubMed |
| 39802957 | Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy. | Ther Clin Risk Manag | 2025 | https://conductscience.org/library/papers/39802957 | PubMed |
| 39168144 | Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications. | Thromb Haemost | 2025 | https://conductscience.org/library/papers/39168144 | PubMed |
| 39046631 | Advances in antitumour therapy with oncolytic herpes simplex virus combinations. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39046631 | PubMed |
| 38241355 | Genome-wide analyses reveal the contribution of somatic variants to the immune landscape of multiple cancer types. | PLoS Genet | 2024 | https://conductscience.org/library/papers/38241355 | PubMed |
| 38188342 | Oncogenes and cancer associated thrombosis: what can we learn from single cell genomics about risks and mechanisms? | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/38188342 | PubMed |
| 36970507 | Podoplanin: A potential therapeutic target for thrombotic diseases. | Front Neurol | 2023 | https://conductscience.org/library/papers/36970507 | PubMed |
| 36434176 | PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma. | Cancer Gene Ther | 2023 | https://conductscience.org/library/papers/36434176 | PubMed |
| 36176432 | Podoplanin: Its roles and functions in neurological diseases and brain cancers. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36176432 | PubMed |
| 36147928 | Based on clinical Ki-67 expression and serum infiltrating lymphocytes related nomogram for predicting the diagnosis of glioma-grading. | Front Oncol | 2022 | https://conductscience.org/library/papers/36147928 | PubMed |
| 35676807 | Identification of hub genes and biological pathways in glioma via integrated bioinformatics analysis. | J Int Med Res | 2022 | https://conductscience.org/library/papers/35676807 | PubMed |
| 34503108 | A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503108 | PubMed |
| 33221817 | Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/33221817 | PubMed |
| 32824685 | IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives. | Molecules | 2020 | https://conductscience.org/library/papers/32824685 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCAT1 | 586 | PubTator's text mining | https://conductscience.org/library/genes/586 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PCNA | 5111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
| PDPN | 10630 | PubTator's text mining | https://conductscience.org/library/genes/10630 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| TAGLN2 | 8407 | PubTator's text mining | https://conductscience.org/library/genes/8407 | NCBI Gene |
| TXN | 7295 | PubTator's text mining | https://conductscience.org/library/genes/7295 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32208352
GET https://conductscience.org/api/papers/v1/32208352/authors?page=2